Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

WALGREENS BOOTS ALLIANCE, INC.

(WBA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Walgreens : Now Offering Moderna and Johnson & Johnson COVID-19 Vaccine Booster Shots Nationwide

10/22/2021 | 09:30am EST

Millions more Americans are now eligible for booster shots as Walgreens remains committed to addressing barriers to access

Walgreens announced today that eligible individuals can now receive Moderna and Johnson & Johnson (J&J) COVID-19 vaccine booster shots in stores nationwide following the Food and Drug Administration (FDA) Emergency Use Authorization and new guidance from the Centers for Disease Control and Prevention (CDC). This follows FDA authorization of a Pfizer booster dose on Sept. 24. As part of this new guidance, eligible populations may also choose to receive a dose different from the one they received for their initial series.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211022005293/en/

New CDC guidance recommends Moderna and J&J COVID-19 vaccine booster shots. (Graphic: Business Wire)

New CDC guidance recommends Moderna and J&J COVID-19 vaccine booster shots. (Graphic: Business Wire)

“As new guidance regarding COVID-19 vaccines continues to emerge, our communities are relying on pharmacists for information, support and guidance more than ever. Walgreens pharmacy teams are available to answer questions and make it easy to understand eligibility requirements and access COVID-19 vaccine, whether it’s a first dose or booster shot,” said Rina Shah, group vice president pharmacy operations and services, Walgreens.

What You Need to Know About Booster Eligibility

  • Moderna COVID-19 Booster Eligibility: Eligibility requirements for Moderna and Pfizer-BioTech booster doses are the same. Individuals must wait at least six months after they complete their initial mRNA COVID-19 primary vaccine series to receive their booster dose. Eligible individuals include:
    • Individuals aged 65 and older.
    • Long-term care facility residents ages 18 and older.
    • Individuals aged 18 and older with underlying medical conditions. Individuals ages 18 – 49 should consider individual benefits and risks, according to CDC guidance.
    • Individuals ages 18-64 who are at an increased risk for COVID-19 exposure and transmission because of occupational or institutional setting, such as healthcare and essential workers, based on their individual benefits and risks.
  • J&J COVID-19 Booster Eligibility: A single vaccine booster dose is recommended for individuals 18 and older who received a J&J primary dose at least 2 months after they receive their initial J&J primary vaccine dose.
  • Mix & Match Guidance: In general, it is recommended individuals receive the same product for their booster dose as they did for their primary series.
    • However, if the original product is not available or another product is preferred, mix and matching vaccines with any of the authorized COVID-19 vaccine boosters is allowed.
    • The primary series of two-dose vaccines should still be completed with the same product for both doses.

Walgreens Remains Committed to Addressing Vaccine Hesitancy

Though the United States has more than enough vaccines for all eligible individuals, vaccination rates remain uneven, leaving Hispanic and Black adults particularly at risk. Since September 20, vaccination rates have increased by 1.2 percentage points among both Hispanic and Black adults, but overall, they remain less likely to have received a vaccine.i Continued hesitancy stemming from medical mistrust or misinformation, and other social determinants of health continue to contribute to disparities in vaccinations among some communities of color.

"As we help millions of Americans get their booster shot, vaccine hesitancy is still a barrier in many communities of color,” said Dr. Kevin Ban, chief medical officer, Walgreens. “As we have throughout the COVID-19 pandemic, Walgreens will remain focused on driving equitable access to COVID-19 vaccines with vaccine equity clinics and educational initiatives.”

In the last month, Walgreens administered nearly 60% of its COVID-19 vaccines to people of color through ongoing equity efforts. Walgreens will continue to prioritize vaccine delivery to medically underserved areas and communities of color that have been disproportionately affected by the pandemic as boosters become available.

How to Schedule Your Vaccine at Walgreens

Appointments for COVID-19 vaccines, booster shots and additional immunizations can be scheduled through Walgreens.com/ScheduleVaccine, by calling 1-800-Walgreens or by calling a local Walgreens store. Individual vaccine availability will vary by location.

For more information, visit Walgreens.com/covidvaccine.

About Walgreens

Walgreens (www.walgreens.com) is included in the United States segment of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), an integrated pharmacy, healthcare and retail leader serving millions of customers and patients every day, with a 170-year heritage of caring for communities. As America’s most loved pharmacy, health and beauty company, Walgreens purpose is to champion the health and well-being of every community in America. Operating nearly 9,000 retail locations across America, Puerto Rico and the U.S. Virgin Islands, Walgreens is proud to be a neighborhood health destination serving approximately 9 million customers each day. Walgreens pharmacists play a critical role in the U.S. healthcare system by providing a wide range of pharmacy and healthcare services. To best meet the needs of customers and patients, Walgreens offers a true omnichannel experience, with fully integrated physical and digital platforms supported by the latest technology to deliver high-quality products and services in local communities nationwide.


i KFF, Latest Data on COVID-19 Vaccinations by Race/Ethnicity, accessed 10/18/2021. https://www.kff.org/coronavirus-covid-19/issue-brief/latest-data-on-covid-19-vaccinations-by-race-ethnicity/


© Business Wire 2021
All news about WALGREENS BOOTS ALLIANCE, INC.
09:29aWalgreens to Buy Remaining Shares in GEHE-Alliance Healthcare JV from McKesson for Undi..
MT
08:09aWalgreens Boots Alliance Acquires Remaining Stake in German GEHE-Alliance Healthcare Jo..
BU
11/26WALGREENS BOOTS ALLIANCE, INC. : Entry into a Material Definitive Agreement, Financial Sta..
AQ
11/24MarketScreener's World Press Review - November 24, 2021
11/23Elizabeth Holmes denies deception at her criminal trial
AQ
11/23Federal Jury Finds CVS, Walmart, Walgreens Contributed to Opioid Crisis in Two Ohio Cou..
MT
11/23Jury holds pharmacies responsible for role in opioid crisis
AQ
11/23US Jury Finds CVS, Walmart, and Walgreens Contributed to the Opioid Epidemic in Two Ohi..
MT
11/23U.s. jury finds pharmacy operators cvs health, walgreens boots alliance and walmart hel..
RE
11/23Theranos founder Holmes denies misleading Walgreens
RE
More news
Analyst Recommendations on WALGREENS BOOTS ALLIANCE, INC.
More recommendations
Financials (USD)
Sales 2022 131 B - -
Net income 2022 3 315 M - -
Net Debt 2022 11 277 M - -
P/E ratio 2022 11,8x
Yield 2022 4,33%
Capitalization 38 779 M 38 779 M -
EV / Sales 2022 0,38x
EV / Sales 2023 0,35x
Nbr of Employees 258 500
Free-Float 61,1%
Chart WALGREENS BOOTS ALLIANCE, INC.
Duration : Period :
Walgreens Boots Alliance, Inc. Technical Analysis Chart | WBA | US9314271084 | MarketScreener
Technical analysis trends WALGREENS BOOTS ALLIANCE, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 22
Last Close Price 44,80 $
Average target price 53,86 $
Spread / Average Target 20,2%
EPS Revisions
Managers and Directors
Rosalind Gates Brewer Chief Executive Officer & Director
John Standley President & Executive Vice President
James Kehoe Global Chief Financial Officer & Executive VP
Stefano Pessina Executive Chairman
Francesco Tinto Global Chief Information Officer & Senior VP
Sector and Competitors